Cambrex Corporation (CBM) in Focus: Stock Up 7.3%

Zacks Equity Research
August 4, 2014


Cambrex Corporation. (CBM) was a big mover last session, as the company saw its shares rise over 7% on the day. This rally higher can be attributable to solid volume too with far more shares changing hands than in a normal session. This broke the recent trend of the company, as the stock is now trading above the volatile price range of $20.25 to $22.08 in the past one-month time frame.

Although the company has seen no estimate revisions over the past 30 days, its Zacks Consensus Estimate moved higher over the same time period, suggesting that more solid trading could be ahead for Cambrex Corporation. So make sure to keep an eye on this stock going forward to see if Friday’s gain can turn into more strength down the road.

Cambrex Corporation currently has a Zacks Rank #3(Hold) while its Earnings ESP is 0.00%.

Other attractive players in the med-biomed industry include Actelion Ltd. (ALIOF) and Illumina Inc. (ILMN), and Enzo Biochem Inc. (ENZ), all carrying a Zacks Rank #1 (Strong Buy).

 Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>






CAMBREX CORP (CBM): Free Stock Analysis Report

ENZO BIOCHEM INC (ENZ): Free Stock Analysis Report

ACTELION LTD (ALIOF): Free Stock Analysis Report

ILLUMINA INC (ILMN): Free Stock Analysis Report


Zacks Investment Research